Allred DC - Search Results

1

Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

Arteaga CL, Kitten LJ, Coronado EB, Jacobs S, Kull FC Jr, Allred DC, Osborne CK. Arteaga CL, et al. Among authors: allred dc. J Clin Invest. 1989 Nov;84(5):1418-23. doi: 10.1172/JCI114315. J Clin Invest. 1989. PMID: 2553774 Free PMC article.

2

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer.

Allred DC, Clark GM, Molina R, Tandon AK, Schnitt SJ, Gilchrist KW, Osborne CK, Tormey DC, McGuire WL. Allred DC, et al. Hum Pathol. 1992 Sep;23(9):974-9. doi: 10.1016/0046-8177(92)90257-4. Hum Pathol. 1992. PMID: 1355464

3

HER-2/neu in node-negative breast cancer: prognostic significance of overexpression influenced by the presence of in situ carcinoma.

Allred DC, Clark GM, Tandon AK, Molina R, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff M, Eudey L, et al. Allred DC, et al. J Clin Oncol. 1992 Apr;10(4):599-605. doi: 10.1200/JCO.1992.10.4.599. J Clin Oncol. 1992. PMID: 1548522 Clinical Trial.

4

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

Osborne CK, Coronado E, Allred DC, Wiebe V, DeGregorio M. Osborne CK, et al. Among authors: allred dc. J Natl Cancer Inst. 1991 Oct 16;83(20):1477-82. doi: 10.1093/jnci/83.20.1477. J Natl Cancer Inst. 1991. PMID: 1920493

5

Aberrant subcellular localization of BRCA1 in breast cancer.

Chen Y, Chen CF, Riley DJ, Allred DC, Chen PL, Von Hoff D, Osborne CK, Lee WH. Chen Y, et al. Among authors: allred dc. Science. 1995 Nov 3;270(5237):789-91. doi: 10.1126/science.270.5237.789. Science. 1995. PMID: 7481765

6

Immunohistochemical studies of early breast cancer evolution.

Allred DC, O'Connell P, Fuqua SA, Osborne CK. Allred DC, et al. Breast Cancer Res Treat. 1994;32(1):13-8. doi: 10.1007/BF00666202. Breast Cancer Res Treat. 1994. PMID: 7819582 Review.

7

The p53 tumor suppressor gene in breast cancer.

Elledge RM, Allred DC. Elledge RM, et al. Among authors: allred dc. Breast Cancer Res Treat. 1994;32(1):39-47. doi: 10.1007/BF00666204. Breast Cancer Res Treat. 1994. PMID: 7819584 Review.

8

Molecular genetic studies of early breast cancer evolution.

O'Connell P, Pekkel V, Fuqua S, Osborne CK, Allred DC. O'Connell P, et al. Among authors: allred dc. Breast Cancer Res Treat. 1994;32(1):5-12. doi: 10.1007/BF00666201. Breast Cancer Res Treat. 1994. PMID: 7819586 Review.

9

Expression of estrogen receptor variants.

Fuqua SA, Allred DC, Auchus RJ. Fuqua SA, et al. Among authors: allred dc. J Cell Biochem Suppl. 1993;17G:194-7. doi: 10.1002/jcb.240531135. J Cell Biochem Suppl. 1993. PMID: 8007697 Review.

10

Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer.

Ravdin PM, Tandon AK, Allred DC, Clark GM, Fuqua SA, Hilsenbeck SH, Chamness GC, Osborne CK. Ravdin PM, et al. Among authors: allred dc. J Clin Oncol. 1994 Mar;12(3):467-74. doi: 10.1200/JCO.1994.12.3.467. J Clin Oncol. 1994. PMID: 8120545

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

173 results

Search Page